Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TriSalus Life Sciences (TLSIW) Preferred Dividend Payments (2023 - 2025)

Historic Preferred Dividend Payments for TriSalus Life Sciences (TLSIW) over the last 3 years, with Q3 2025 value amounting to $11.9 million.

  • TriSalus Life Sciences' Preferred Dividend Payments rose 138779.58% to $11.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.2 million, marking a year-over-year increase of 34168.49%. This contributed to the annual value of $3.2 million for FY2024, which is 15341.81% up from last year.
  • TriSalus Life Sciences' Preferred Dividend Payments amounted to $11.9 million in Q3 2025, which was up 138779.58% from $714000.0 recorded in Q2 2025.
  • Over the past 5 years, TriSalus Life Sciences' Preferred Dividend Payments peaked at $11.9 million during Q3 2025, and registered a low of $458000.0 during Q3 2023.
  • Its 3-year average for Preferred Dividend Payments is $2.0 million, with a median of $800000.0 in 2023.
  • Over the last 5 years, TriSalus Life Sciences' Preferred Dividend Payments had its largest YoY gain of 138779.58% in 2025, and its largest YoY loss of 1111.11% in 2025.
  • Quarter analysis of 3 years shows TriSalus Life Sciences' Preferred Dividend Payments stood at $800000.0 in 2023, then dropped by 2.12% to $783000.0 in 2024, then soared by 1425.8% to $11.9 million in 2025.
  • Its last three reported values are $11.9 million in Q3 2025, $714000.0 for Q2 2025, and $712000.0 during Q1 2025.